Recommendations for transfusion medicine

Choosing Wisely is a global initiative that seeks to encourage both doctors and patients to have a conversation about the value of treatments. The below recommendations for transfusion medicine are the result of a Choosing Wisely consultation involving the College.  

 

Recommendation 1: Don't give a patient a blood transfusion without informing them about the risks and benefits (although do not delay emergency transfusion).

 

Evidence/guidance are lised below.

There is a lack of high-quality research in this field with largely observational data available. The evidence suggests that patients have a limited understanding of many aspects of transfusion, but that they do want to be part of an informed decision-making process. The evidence also indicates that patients are reassured by the provision of written information.

Patient information/decision aids are listed below.

 

Recommendation 2: Don't transfuse red cells for iron deficiency anaemia without haemodynamic instability. 

 

 

Evidence/guidance are listed below.

Patient information/decision aids are listed below.

 

Recommendation 3: Only consider transfusing platelets for patients with chemotherapy-induced thrombocytopenia where the platelet count is <10 X 109/L except when the patient has clinical significant bleeding or will be undergoing a procedure with a high risk of bleeding.

 

 

 

Recommendation 4: When restrictive thresholds for patients needing red cell transfusions and give only one unit at a time except when the patient has active bleeding.

 

 

Evidence/guidance are listed below.

 

Recommendation 5: Only transfuse O Rh D negative red cells to O Rh D negative patients and in emergencies for females of childbearing potential with unknown blood group.